IMPAX Laboratories

Drug pricing spotlight shifts to generics with no rivals

September 03, 2015

UCB far from rehabilitated, despite divestment and study success

September 10, 2014

Keryx and Galenica face a tough battle to build phosphate franchises

February 27, 2013

Biotie and UCB tie the knot with pivotal trial pre-nup

January 21, 2013

More off time for Impax as FDA rejects Rytary

December 24, 2012

Midcap players ask Europe to bring it on in 2013

October 04, 2012

Same, same but different Wellbutrin could cause problems for generics companies

October 03, 2012

Event – Impax hopes for some originality with Rytary approval

July 20, 2012

Key regulatory events for the next six months

June 25, 2012

Shire needs pipeline focus to recover from early Adderall blow

August 10, 2010

No brainer for Endo as Penwest activists win the day

Load More